For: | Cai HY, Wang XH, Tian Y, Gao LY, Zhang LJ, Zhang ZY. Changes of serum p53 antibodies and clinical significance of radiotherapy for esophageal squamous cell carcinoma. World J Gastroenterol 2008; 14(25): 4082-4086 [PMID: PMC2725350 DOI: 10.3748/wjg.14.4082] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i25/4082.htm |
Number | Citing Articles |
1 |
Abhilash Perisetti, Mahita Bellamkonda, Manojna Konda, Samantha Edwards, Salman Ali Khan, Pardeep Bansal, Zhi-De Hu, Hemant Goyal. Tumor-associated antigens and their antibodies in the screening, diagnosis, and monitoring of esophageal cancers. European Journal of Gastroenterology & Hepatology 2020; 32(7): 779 doi: 10.1097/MEG.0000000000001718
|
2 |
Pierre Blanchard, Laurent Quero, Vincent Pacault, Marie-Helene Schlageter, Valerie Baruch-Hennequin, Christophe Hennequin. Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-119
|
3 |
Hongfei Zhang, Junfen Xia, Kaijuan Wang, Jianying Zhang. Serum autoantibodies in the early detection of esophageal cancer: a systematic review. Tumor Biology 2015; 36(1): 95 doi: 10.1007/s13277-014-2878-9
|
4 |
Zhi-Cheng Yang, Li Ling, Zhi-Wei Xu, Xiao-Dong Sui, Shuang Feng, Jun Zhang. Are p53 Antibodies a Diagnostic Indicator for Patients with Oral Squamous Cell Carcinoma? Systematic Review and Meta-Analysis. Asian Pacific Journal of Cancer Prevention 2016; 17(1): 109 doi: 10.7314/APJCP.2016.17.1.109
|
5 |
Carlos S. Cabalag, Jonathan Sivakumar, Cuong P. Duong. GI Surgery Annual. GI Surgery Annual 2022; 26: 147 doi: 10.1007/978-981-19-0828-6_8
|
6 |
Reiping Tang, Chien Yuh Yeh, Jeng-Yi Wang, Chung Rong Changchien, Jinn-Shiun Chen, Ling Ling Hsieh. Serum p53 Antibody as Tumor Marker for Follow-Up of Colorectal Cancer After Curative Resection. Annals of Surgical Oncology 2009; 16(9): 2516 doi: 10.1245/s10434-009-0578-2
|
7 |
Jun Zhang, Zhiwei Xv, Xuefeng Wu, Ke Li, Hamid Reza Baradaran. Potential Diagnostic Value of Serum p53 Antibody for Detecting Esophageal Cancer: A Meta-Analysis. PLoS ONE 2012; 7(12): e52896 doi: 10.1371/journal.pone.0052896
|
8 |
Hideaki Shimada, Satoshi Yajima, Yoko Oshima, Takaki Hiwasa, Masatoshi Tagawa, Kazuyuki Matsushita, Fumio Nomura. Impact of serum biomarkers on esophageal squamous cell carcinoma. Esophagus 2012; 9(3): 131 doi: 10.1007/s10388-012-0332-x
|
9 |
Kotaro Yamashita, Tomoki Makino, Koji Tanaka, Makoto Yamasaki, Masaaki Yamamoto, Yasuhiro Miyazaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Kiyokazu Nakajima, Shuji Takiguchi, Masaki Mori, Yuichiro Doki. Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery. World Journal of Surgery 2017; 41(6): 1566 doi: 10.1007/s00268-017-3894-x
|
10 |
Ananya Sah, Debasree Sarkar, Sejal Shah. Autoantibodies:Powerful Biomakers in Cancer and Autoimmune Disease Precision Medicine. 2023 2nd International Conference on Ambient Intelligence in Health Care (ICAIHC) 2023; : 1 doi: 10.1109/ICAIHC59020.2023.10431442
|
11 |
Yi-Wei Xu, Yu-Hui Peng, Bo Chen, Zhi-Yong Wu, Jian-Yi Wu, Jin-Hui Shen, Chun-Peng Zheng, Shao-Hong Wang, Hai-Peng Guo, En-Min Li, Li-Yan Xu. Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma. American Journal of Gastroenterology 2014; 109(1): 36 doi: 10.1038/ajg.2013.384
|
12 |
Bozena Dobrzycka, Slawomir J. Terlikowski, Andrzej Mazurek, Oksana Kowalczuk, Wieslawa Niklinska, Lech Chyczewski, Marek Kulikowski. Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer. International Journal of Cancer 2010; 127(3): 612 doi: 10.1002/ijc.25077
|
13 |
Hiedaki Shimada, Matsuo Nagata, Yoshihiro Nabeya, Satoshi Yajima, Yoko Oshima, Makiko Itami. Paradoxical changing of serum p53 antibody titers during chemotherapy for a stage IV esophageal squamous cell carcinoma. International Cancer Conference Journal 2014; 3(4): 232 doi: 10.1007/s13691-014-0153-y
|
14 |
Hideaki Shimada, Matsuo Nagata, Akihiro Cho, Nobuhiro Takiguchi, Osamu Kainuma, Hiroaki Soda, Atsushi Ikeda, Yoshihiro Nabeya, Satoshi Yajima, Hiroshi Yamamoto, Takahiro Sugiyama, Makiko Itami. Long-term monitoring of serum p53 antibody after neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: report of a case. Surgery Today 2014; 44(10): 1957 doi: 10.1007/s00595-013-0787-y
|
15 |
Jun Zhang, Zhenli Zhu, Yan Liu, Xueyuan Jin, Zhiwei Xu, Qiuyan Yu, Ke Li, William B. Coleman. Diagnostic Value of Multiple Tumor Markers for Patients with Esophageal Carcinoma. PLOS ONE 2015; 10(2): e0116951 doi: 10.1371/journal.pone.0116951
|
16 |
Yi-Wei Xu, Yu-Hui Peng, Li-Yan Xu, Jian-Jun Xie, En-Min Li. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. World Journal of Gastroenterology 2019; 25(34): 5049-5068 doi: 10.3748/wjg.v25.i34.5049
|
17 |
Ling-Yu Chu, Yu-Hui Peng, Xue-Fen Weng, Jian-Jun Xie, Yi-Wei Xu. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. World Journal of Gastroenterology 2020; 26(15): 1708-1725 doi: 10.3748/wjg.v26.i15.1708
|
18 |
Sharda Yadav, Navid Kashaninejad, Mostafa Kamal Masud, Yusuke Yamauchi, Nam-Trung Nguyen, Muhammad J.A. Shiddiky. Autoantibodies as diagnostic and prognostic cancer biomarker: Detection techniques and approaches. Biosensors and Bioelectronics 2019; 139: 111315 doi: 10.1016/j.bios.2019.111315
|
19 |
Wei-Lei Yang, Aleksandra Gentry-Maharaj, Archana Simmons, Andy Ryan, Evangelia Ourania Fourkala, Zhen Lu, Keith A. Baggerly, Yang Zhao, Karen H. Lu, David Bowtell, Ian Jacobs, Steven J. Skates, Wei-Wu He, Usha Menon, Robert C. Bast. Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer. Clinical Cancer Research 2017; 23(19): 5912 doi: 10.1158/1078-0432.CCR-17-0284
|